Comparison of spirometric markers of severity and reversibility in patients with asthma and/or COPD in NOVELTY
R. Hughes (Cambridge, United Kingdom), R. Del Olmo (Buenos Aires, Argentina), B. Make (Denver, CO, United States of America), D. Price (Aberdeen, United Kingdom), A. Agustí (Barcelona, Spain), E. Rapsomaniki (Cambridge, United Kingdom), H. Müllerová (Cambridge, United Kingdom), J. Vestbo (Manchester, United Kingdom)
Source: Virtual Congress 2020 – New tools for risk stratification of obstructive diseases
Disease area: Airway diseases
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
R. Hughes (Cambridge, United Kingdom), R. Del Olmo (Buenos Aires, Argentina), B. Make (Denver, CO, United States of America), D. Price (Aberdeen, United Kingdom), A. Agustí (Barcelona, Spain), E. Rapsomaniki (Cambridge, United Kingdom), H. Müllerová (Cambridge, United Kingdom), J. Vestbo (Manchester, United Kingdom). Comparison of spirometric markers of severity and reversibility in patients with asthma and/or COPD in NOVELTY. 3759
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you:
Comparison of spirometric z-scores with FEV1 percent prediction in predicting exacerbations in elderly COPD patients Source: International Congress 2016 – In-patient and out-patient COPD management Year: 2016
Characteristics by physician-assigned severity of asthma, asthma+COPD and COPD patients in the NOVELTY study Source: International Congress 2019 – Clinical implications of asthma management Year: 2019
Impact of severity on three spirometric definitions of COPD Source: Eur Respir J 2002; 20: Suppl. 38, 123s Year: 2002
Patterns of bronchodilator reversibility of FEV1 in asthma and COPD patients Source: Annual Congress 2012 - Translational respiratory medicine in asthma and COPD Year: 2012
Frequency and severity of exacerbations reflect COPD severity, but not COPD phenotype as determined by quantitative CT Source: International Congress 2014 – Markers Year: 2014
Clinical characteristics of patients with clinically-diagnosed COPD exacerbations but without concomitant airflow limitation Source: International Congress 2015 – Notable abstracts in exacerbations, mechanisms and biomarkers in COPD Year: 2015
Factors associated with physician assessment of severity of asthma or COPD in NOVELTY Source: Virtual Congress 2020 – New tools for diagnosis of obstructive diseases Year: 2020
Markers of T2-inflammation in patients with severe asthma and concomitant COPD Source: Virtual Congress 2020 – News on clinical evaluation of bronchiectasis, cough and inflammatory disease Year: 2020
Clinical markers of disease severity in the assessment of airway inflammation in patients with persistent asthma Source: Eur Respir J 2001; 18: Suppl. 33, 335s Year: 2001
Assessing bronchodilator response in patients with asthma and COPD using 19F-MRI Source: Virtual Congress 2020 – New imaging techniques applied to old problems Year: 2020
Additional value of spirometry in risk assessment of acute respiratory disease in winter among patients with mild to moderate asthma or COPD Source: Eur Respir J 2002; 20: Suppl. 38, 473s Year: 2002
Evaluation of the individual bronchodilator response in patients with severe COPD Source: Eur Respir J 2002; 20: Suppl. 38, 246s Year: 2002
Baseline characteristics of COPD patients with frequent COPD exacerbations in tiotropium trials Source: Eur Respir J 2006; 28: Suppl. 50, 175s Year: 2006
Comparison of clinical characteristics between stable COPD patients with- and without mild bronchiectasis Source: Eur Respir J 2002; 20: Suppl. 38, 257s Year: 2002
The association between airway and systemic eosinophilia and symptoms and exacerbations differ between asthma and COPD patients Source: Virtual Congress 2020 – Monitoring of inflammation in remodelling Year: 2020
Eosinophilic phenotype classification of patients with asthma and/or COPD in NOVELTY Source: Virtual Congress 2021 – Biomarkers to phenotype asthma: prediction of exacerbations Year: 2021
Correlation between indices of quality of life and degree of severity of symptoms in patients with asthma in combination with COPD Source: Eur Respir J 2004; 24: Suppl. 48, 520s Year: 2004
COPD patients with asthma, characteristics and risk of exacerbations Source: International Congress 2019 – Multimorbidity in airway diseases and appropriate inhaled corticosteroid use in COPD Year: 2019
The relationship between COPD assessment test (CAT) scores and severity of airflow obstruction in stable COPD patients Source: Annual Congress 2012 - Quality of life and clinical parametres in monitoring airway diseases Year: 2012
Correlation between indices of quality of life and spirography in patients with asthma in combination with COPD Source: Eur Respir J 2002; 20: Suppl. 38, 46s Year: 2002